Q32 Bio Inc (QTTB NASDAQ) stock market data APIs
$15.7558
0.05(0.3%)
as of July 31, 2026
Try our APIs with
free plan!
Q32 Bio Inc Financial Data Overview
Price chart is built with
Anychart
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Prev. Close
15.7558
Open
15.8058
High
16.1122
Low
14.975
52 wk Range
1.5685-23.57
Market Cap
466 M
P/E Ratio
5.6403
Shares Outstanding
29 709 K
Revenue
53 737 K
Beta
-0.272
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Q32 Bio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Q32 Bio Inc data using free add-ons & libraries
Get Q32 Bio Inc Fundamental Data
Q32 Bio Inc Fundamental data includes:
- Net Revenue: 53 737 K
- EBITDA: 21 770 K
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -0.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Q32 Bio Inc News
New
Q32 Bio prices $200M equity raise
* Q32 Bio (QTTB [https://seekingalpha.com/symbol/QTTB]) priced [https://seekingalpha.com/pr/20583043-q32-bio-announces-pricing-of-200-million-public-offering-of-common-stock-and-pre-funded] an under...
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
(RTTNews) - Today's top biotech gainers include Q32 Bio, following positive Phase 2 results for its hair loss treatment; Agenus, as it advances development of its colon cancer drug combination, botens...
Why Q32 Bio Stock Skyrocketed Today
Key Points Q32 Bio is striving to develop a safe and effective therapy for alopecia areata. Wall Street is excited about the data from a recent clinical study.10 stocks we like better than Q32 Bio �...
Q32 Bio announces $200M offering of common stock and pre-funded warrants
Q32 Bio (QTTB [https://seekingalpha.com/symbol/QTTB]) announced on Monday that it has commenced an underwritten public offering of $200M of shares of its common stock and, in lieu of common stock to c...
Get Q32 Bio Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
